Ami Bhatt is an American physician-scientist who studies the link between blood cancers and the human gut microbiome.[1] She holds associate professorships in Genetics and Medicine (Hematology) at Stanford University. She is a member of Stanford Bio-X, the Stanford Cancer Institute, Stanford Maternal & Child Health Research Institute (MCHRI), and Stanford ChEM-H.[2][3] In addition, Bhatt is the co-founder of Global Oncology Inc., a nonprofit focused on providing quality oncologic treatment in resource-constrained settings.[4]
Ami Bhatt | |
|---|---|
| Alma mater | University of California, San Francisco Harvard School of Medicine |
| Awards | Chen Award of Excellence, Human Genome Organization (2018)
Emerging Leader in Health and Medicine, National Academy of Medicine (2020) Sloan Research Fellowship (2020) |
| Scientific career | |
| Fields | Microbiome, hematologic malignancies, bioinformatics |
| Institutions | Stanford University |
| Website | www |
Education
editBhatt completed her PhD in Biochemistry and Molecular Biology in 2005 and earned her MD degree in 2007, both from the University of California, San Francisco.[2] She then underwent her residency and chief residency in Internal Medicine at Brigham and Women's Hospital, a teaching hospital of Harvard Medical School.[1][2] Bhatt then pursued a Hematology and Oncology fellowship at the Dana-Farber Cancer Institute. After this she was a post-doc at the Broad Institute and MIT.[5][6]
Awards
editBhatt won the 2018 Chen Award of Excellence by the Human Genome Organisation.[7]
The Chan Zuckerberg Initiative awarded a $525,000 research grant to Bhatt, along with colleagues Anne Brunet and K. Christopher Garcia, for their project "Analyzing how inflammation affects the aging brain."[8]
Bhatt was named a 2020 Emerging Leader in Health and Medicine by the National Academy of Medicine.[9] She was also a winner of the 2020 Sloan Research Fellowship, in the category "Computational and Evolutionary Molecular Biology."[10]
Board memberships
editBhatt serves on the editorial board for Blood, Journal of Global Oncology,[11] Seminars in Hematology, and The Oncologist.[2]
In November 2020 Bhatt joined the Scientific Advisory board for January AI, a precision medicine company predicting long-term blood glucose level changes with artificial intelligence.[12]
References
edit- ^ a b "People". Bhatt Lab - Stanford Medical School. Retrieved 2021-01-02.
- ^ a b c d "Ami Bhatt's Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2021-01-02.
- ^ Conger, Krista. "Human microbiome churns out thousands of tiny novel proteins". News Center. Retrieved 2021-01-02.
- ^ "About - GLOBAL ONCOLOGY, INC". globalonc.org. Retrieved 2021-01-03.
- ^ "Midsummer Nights' Science: Explorations of human disease: The bacterial frontier". Broad Institute. 2014-07-09. Retrieved 2021-01-03.
- ^ "Researcher Dr. Ami Bhatt in Conversation". Emerson Collective. Retrieved 2021-01-03.
- ^ "Chen Award Recipient 2018". hugo-international.org. Retrieved 2021-01-02.
- ^ "Chan Zuckerberg Initiative awards $1.49 million to Stanford researchers". news.stanford.edu. Archived from the original on June 14, 2020. Retrieved 2021-01-02.
- ^ Reporter, India-West Staff. "Stanford Indian American Professor Ami S. Bhatt Named a National Academy of Medicine Scholar". India West. Retrieved 2021-01-02.
- ^ "2020 Fellows". sloan.org. Archived from the original on 2020-09-25. Retrieved 2021-01-02.
- ^ "Post #5005 - GLOBAL ONCOLOGY, INC". globalonc.org. Retrieved 2021-01-02.
- ^ "January AI Expands Scientific Advisory Board". www.businesswire.com. 2020-11-11. Retrieved 2021-01-02.